175 related articles for article (PubMed ID: 36240260)
1. N-terminal peptide fragment constitutes core of amyloid deposition of serum amyloid A: An imaging mass spectrometry study.
Shintani-Domoto Y; Sugiura Y; Ogawa M; Sugiyama E; Abe H; Sakatani T; Ohashi R; Ushiku T; Fukayama M
PLoS One; 2022; 17(10):e0275993. PubMed ID: 36240260
[TBL] [Abstract][Full Text] [Related]
2. Topologies of amyloidogenic proteins in Congo red-positive sliced sections of formalin-fixed paraffin embedded tissues by MALDI-MS imaging coupled with on-tissue tryptic digestion.
Nakanishi T; Ito M; Nirasawa T; Tsuji M; Takubo T
Clin Biochem; 2013 Oct; 46(15):1595-600. PubMed ID: 23732480
[TBL] [Abstract][Full Text] [Related]
3. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
[TBL] [Abstract][Full Text] [Related]
4. Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats.
Gaffney PM; Barr B; Rowe JD; Bett C; Drygiannakis I; Giannitti F; Trejo M; Ghassemian M; Martin P; Masliah E; Sigurdson CJ
FASEB J; 2015 Mar; 29(3):911-9. PubMed ID: 25422367
[TBL] [Abstract][Full Text] [Related]
5. MALDI mass spectrometry imaging unravels organ and amyloid-type specific peptide signatures in pulmonary and gastrointestinal amyloidosis.
Schürmann J; Gottwald J; Rottenaicher G; Tholey A; Röcken C
Proteomics Clin Appl; 2021 Nov; 15(6):e2000079. PubMed ID: 34061454
[TBL] [Abstract][Full Text] [Related]
6. Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis.
Moderer T; Puşcalău-Gîrţu I; Haupt C; Baur J; Rodríguez-Alfonso A; Wiese S; Schmidt CQ; Malešević M; Forssmann WG; Ständker L; Fändrich M
Amyloid; 2023 Dec; 30(4):424-433. PubMed ID: 37431668
[TBL] [Abstract][Full Text] [Related]
7. MALDI Mass Spectrometry Imaging: A Novel Tool for the Identification and Classification of Amyloidosis.
Winter M; Tholey A; Kristen A; Röcken C
Proteomics; 2017 Nov; 17(22):. PubMed ID: 28994248
[TBL] [Abstract][Full Text] [Related]
8. Post-translational modification of amyloid a protein in patients with AA amyloidosis.
Kluve-Beckerman B; Smith JT; Ivancic C; Benson MD
Amyloid; 2022 Mar; 29(1):50-57. PubMed ID: 34787027
[TBL] [Abstract][Full Text] [Related]
9. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
Liepnieks JJ; Kluve-Beckerman B; Benson MD
Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
[TBL] [Abstract][Full Text] [Related]
10. Transformation from SAA2-fibrils to AA-fibrils in amyloid fibrillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies.
Arai K; Miura K; Baba S; Shirasawa H
J Pathol; 1994 Jun; 173(2):127-34. PubMed ID: 8089807
[TBL] [Abstract][Full Text] [Related]
11. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.
Meek RL; Hoffman JS; Benditt EP
J Exp Med; 1986 Mar; 163(3):499-510. PubMed ID: 3950541
[TBL] [Abstract][Full Text] [Related]
12. Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies.
Bindi G; Smith A; Oliveira G; Eccher A; Vatrano S; Alberici F; Cazzaniga G; Galimberti S; Capitoli G; Magni F; Pagni F; L'Imperio V
J Clin Pathol; 2024 May; 77(6):402-410. PubMed ID: 36813560
[TBL] [Abstract][Full Text] [Related]
13. Pathology and diagnosis of renal non-AL amyloidosis.
Sethi S; Theis JD
J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis and biochemistry of amyloidosis.
Cohen AS; Connors LH
J Pathol; 1987 Jan; 151(1):1-10. PubMed ID: 3550020
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
[TBL] [Abstract][Full Text] [Related]
16. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
Lim A; Wally J; Walsh MT; Skinner M; Costello CE
Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of amyloid proteins.
Benson MD; Kluve-Beckerman B; Liepnieks JJ; Murrell JR; Hanes D; Uemichi T
Ciba Found Symp; 1996; 199():104-13; discussion 113-8. PubMed ID: 8915606
[TBL] [Abstract][Full Text] [Related]
18. Pathogenetic mechanisms of amyloid A amyloidosis.
Simons JP; Al-Shawi R; Ellmerich S; Speck I; Aslam S; Hutchinson WL; Mangione PP; Disterer P; Gilbertson JA; Hunt T; Millar DJ; Minogue S; Bodin K; Pepys MB; Hawkins PN
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16115-20. PubMed ID: 23959890
[TBL] [Abstract][Full Text] [Related]
19. Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.
Patke S; Maheshwari R; Litt J; Srinivasan S; Aguilera JJ; Colón W; Kane RS
Biochemistry; 2012 Apr; 51(14):3092-9. PubMed ID: 22448726
[TBL] [Abstract][Full Text] [Related]
20. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.
Magy N; Benson MD; Liepnieks JJ; Kluve-Beckerman B
Amyloid; 2007 Mar; 14(1):51-63. PubMed ID: 17453625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]